Amsterdam-based medical device company Koninklijke Philips N.V. (Philips) agreed last Thursday to resolve its Foreign Corrupt Practices Act (FCPA) enforcement action by paying the SEC $62m for violations that occurred in China.
The SEC charged Philips in an administrative order with violating the FCPA’s books and records and internal accounting controls provisions.